Skip to main content

Advertisement

ADVERTISEMENT

Psoriatic Arthritis

Joseph Merola
Conference Coverage
07/19/2023
Dr Merola and colleagues conducted a post hoc analysis of the KEEPsAkE 1 and 2 trials of risankizumab among patients with active psoriatic arthritis to evaluates patient subgroups at 52 weeks of treatment.
Dr Merola and colleagues conducted a post hoc analysis of the KEEPsAkE 1 and 2 trials of risankizumab among patients with active psoriatic arthritis to evaluates patient subgroups at 52 weeks of treatment.
Dr Merola and colleagues...
07/19/2023
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
03/17/2023
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of...
03/17/2023
Rheumatology & Arthritis
Laura Coates
Conference Coverage
02/22/2023
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at ACR Convergence examining the efficacy of upadacitinib vs adalimumab in treating psoriatic arthritis, using the RAPID3 tool to assess disease activity.
Dr Coates presented a poster at...
02/22/2023
Rheumatology & Arthritis
Alexis Ogdie, MD
Conference Coverage
02/13/2023
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of...
02/13/2023
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
11/14/2022
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of...
11/14/2022
Rheumatology & Arthritis
woman in hospital
Conference Coverage
07/22/2022
A study presented at ACR Convergence 2021 shows that patients with psoriatic arthritis who also suffer from fatigue incurred higher resource use and health care costs than those without fatigue.
A study presented at ACR Convergence 2021 shows that patients with psoriatic arthritis who also suffer from fatigue incurred higher resource use and health care costs than those without fatigue.
A study presented at ACR...
07/22/2022
Rheumatology & Arthritis
spinal xray
Conference Coverage
02/18/2022
A new study demonstrates that patients with psoriatic arthritis, as in other inflammatory diseases, are at higher risk of fractures in the vertebrae.
A new study demonstrates that patients with psoriatic arthritis, as in other inflammatory diseases, are at higher risk of fractures in the vertebrae.
A new study demonstrates that...
02/18/2022
Rheumatology & Arthritis
Orbai
Podcast
01/31/2022
Dr Orbai, from Johns Hopkins University, discusses her project to validate the PROMIS 29 profile for use in assessing several disease domains among patients with psoriatic arthritis, which she spoke about at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins University, discusses her project to validate the PROMIS 29 profile for use in assessing several disease domains among patients with psoriatic arthritis, which she spoke about at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins...
01/31/2022
Rheumatology & Arthritis
Orbai
Podcast
12/07/2021
Dr Orbai, from Johns Hopkins University, recaps a presentation on the findings of a trial of guselkumab for the treatment of psoriatic arthritis at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins University, recaps a presentation on the findings of a trial of guselkumab for the treatment of psoriatic arthritis at ACR Convergence 2021.
Dr Orbai, from Johns Hopkins...
12/07/2021
Rheumatology & Arthritis
phone & laptop
Conference Coverage
11/18/2021
Researchers presented an abstract at ACR Convergence 2021 examining how collaborative care by rheumatologists and dermatologists can benefit patients with psoriasis and psoriatic arthritis.
Researchers presented an abstract at ACR Convergence 2021 examining how collaborative care by rheumatologists and dermatologists can benefit patients with psoriasis and psoriatic arthritis.
Researchers presented an...
11/18/2021
Rheumatology & Arthritis
CT
Conference Coverage
11/12/2021
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the...
11/12/2021
Rheumatology & Arthritis
Eyeball
Conference Coverage
11/08/2021
Study findings show the hazard ratio for uveitis was significantly higher among patients with psoriatic arthritis compared to the general population.
Study findings show the hazard ratio for uveitis was significantly higher among patients with psoriatic arthritis compared to the general population.
Study findings show the hazard...
11/08/2021
Rheumatology & Arthritis
person holding knee
Conference Coverage
11/07/2021
A phase 3 trial tests upacitinib and adalimumab for pain relief among patients with psoriatic arthritis and shows association with other improvements in patient-reported outcomes.
A phase 3 trial tests upacitinib and adalimumab for pain relief among patients with psoriatic arthritis and shows association with other improvements in patient-reported outcomes.
A phase 3 trial tests upacitinib...
11/07/2021
Rheumatology & Arthritis
woman and doctor
Conference Coverage
11/16/2011
Higher rates of annual short-term disability were observed among patients with PsA and fatigue than without fatigue, according to a study presented at ACR Convergence 2021.
Higher rates of annual short-term disability were observed among patients with PsA and fatigue than without fatigue, according to a study presented at ACR Convergence 2021.
Higher rates of annual...
11/16/2011
Gastroenterology
man with tape measure
Conference Coverage
11/04/2011
Study findings suggest changes in patient-reported outcomes measures were lowest among patients with PsA and obesity compared to other BMI categories.
Study findings suggest changes in patient-reported outcomes measures were lowest among patients with PsA and obesity compared to other BMI categories.
Study findings suggest changes...
11/04/2011
Rheumatology & Arthritis

Advertisement